Skip to content
Home/GPs/Parkwalk Advisors
Parkwalk Advisors

Parkwalk Advisors

London, United Kingdom·Founded 2009··parkwalk.vc

Parkwalk Advisors Ltd is the UK's most active investor in university spinouts, managing c.£500 million in assets under management as the leading Enterprise Investment Scheme (EIS) fund manager focused on knowledge-intensive technology businesses spun out of leading UK universities including Oxford, Cambridge, Imperial College London, Bristol, Manchester, Leeds and Sheffield. Founded in 2009 and acquired by IP Group plc in 2017, Parkwalk has backed over 200 university spinouts and delivered more than £200 million cash returns to its EIS investors across 70+ exits. The firm is authorised and regulated by the UK Financial Conduct Authority under firm reference number 502237 (Companies House number 06925696). Its flagship Opportunities EIS Fund has raised the largest growth EIS fund in the UK market for five of the past six tax years. Registered address: 3 Pancras Square, London N1C 4AG.

AUM
€585M
Funds
2
vintages 2009–2021
Portfolio
1
Exits
7
SectorsTMTSoftwareHealthcareIndustrials

Key facts

HQLondon, United Kingdom
Founded2009

Recent exits

Cytora
Software · 2025 · 10yr hold
PetMedix
Biotech · 2023 · 4yr hold
Flusso
Deep Tech · 2022 · 2yr hold
YASA
Mobility · 2021 · 9yr hold

Coverage notes

2 funds tracked, 8 portfolio companies (1 active · 7 realized). Verified weekly from public filings and deal announcements.

Funds & portfolio

Every fund Parkwalk Advisors has raised, with its portfolio companies. Hand-checked from public filings.

2 funds
Parkwalk Knowledge Intensive EIS FundVC
2021 · 5yr€83M1 active

Unrealized

1 held
Deep TechUK· Entry 2023
Parkwalk Opportunities EIS FundVC
2009 · 17yr€585M0 active · 7 realized

Realized

7 exits
CytoraExited 2025
SoftwareUK· Entry 2015
Trade Saleto
FlussoExited 2022
Deep TechUK· Entry 2020
Trade Saleto
BiotechUK· Entry 2013
Secondary
JukedeckExited 2019
AI/MLUK· Entry 2014
Trade Saleto
PetMedixExited 2023
BiotechUK· Entry 2019
Trade Saleto
VocalIQExited 2015
AI/MLUK· Entry 2014
Trade Saleto
YASAExited 2021
MobilityUK· Entry 2012
Trade Saleto
Track Parkwalk Advisors

Saved GPs appear in your watchlist, one click from your workspace.

About Parkwalk Advisors

Parkwalk Advisors is the UK's most active university spinout investor with approximately £450 million of assets under management as of December 2024 (£483.4 million deployed across 200 companies by June 2025), headquartered in London at 3 Pancras Square, King's Cross. The firm was founded in 2009 as a university spinout EIS specialist before being acquired by IP Group plc in 2017, now operating as a wholly-owned subsidiary of IP Group plc (LSE: IPO). Parkwalk completed 41 deals in 2024 (54 with IP Group).

Investment thesis

Parkwalk Advisors deploys capital through 15 plus EIS funds across two main families: the Opportunities EIS Fund (annual vintages since 2011) and the Knowledge Intensive EIS Fund (Funds I-V since 2021). The platform provides EIS and Knowledge Intensive EIS fund management with early-stage to scale-up co-investment alongside parent IP Group in university spinouts. Sector focus spans deep tech (AI, quantum, hardware, advanced materials), healthtech and digital health and life sciences and cleantech (agtech, future mobility, energy). Geographic deployment is UK-only with focus on spinouts from Oxford, Cambridge, Imperial, UCL, Manchester, Bristol, Southampton and Leeds.

Recent activity

Recent realised exits include insurtech and AI (2025) and quantum computing (2025, co-investment with Oxford Capital in Oxford Ionics). Recent acquisitions include quantum computing follow-on (2026), hardware and metrology (2026) and hardware seed (2026). The platform continues active deployment across the UK university spinout franchise. Detailed buyer names and multiple data available on Pro at €29/month.

Investment team

Senior partners. Hand-checked from public filings and the firm's own site.

Moray Wright
Chief Executive Officer
John Pearson
Chief Investment Officer
Alun Williams
Investment Director
Anne Dobrée
Investment Director
Neil Cameron
Investment Director
Martin Glen
Investment Director
Last updated March 2026 · Sourced from public filings